ArriVent BioPharma, Inc. Common StockAVBPNASDAQ
Loading
Cash generated from core business operations
Latest
$-160.59M
↓ 134% vs avg
Percentile
P0
Near historical low
Streak
4 yr
Consecutive declineContracting
Average
$-68.57M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-160.59M | -128.7% |
| 2024 | $-70.21M | -25.7% |
| 2023 | $-55.84M | -28.0% |
| 2022 | $-43.63M | -246.6% |
| 2021 | $-12.59M | - |